Skip to content

Study · Not a test of the peptide alone · 2024

1 result

A Neurofilament-L reporter cell line for the quantification of early neuronal differentiation: A Bioassay for neurotrophic activities.

Seidl LF, Winter S, Aigner L, Schartner J

Heliyon17 Jan 2024Cited by 2 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 01LabNot a test of Cerebrolysin aloneIn vitro (cells)Other

    In EGFP-NF-L reporter PC12 cells, testing with Cerebrolysin demonstrated a robust, specific, and reproducible Neurofilament-L Bioassay.

    In plain wordsIn cells, testing with Cerebrolysin demonstrated a robust, specific, and reproducible Neurofilament-L Bioassay.

    Outcome
    Not applicableNeurofilament-L Bioassay performance
    Study

    ratn: not reported in source

    EGFP-NF-L reporter PC12 cells
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    Using Cerebrolysin® as a role model for a pharmacological compound that stimulates neurotrophic activity in the central nervous system, the Neurofilament-L Bioassay was proved to be a robust, specific, and reproducible method.
    1 context sentence
    Summary · context
    We generated and characterized an enhanced green fluorescent protein (EGFP)-NF-L reporter PC12 cell line for the development of a cell-based assay (designated Neurofilament-L Bioassay) that allows straightforward quantification of early neuronal differentiation based on NF-L expression.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.